Maui firefighters describe their harrowing efforts to battle the fire that destroyed the city of Lahaina. The FDA rejects a drug that would have been the first needle-free alternative to EpiPens. And rising olive oil prices are leading to robberies. Here’s what you should know today. Fighting the beast: Firefighters recall desperate search to save … Read more
The Food and Drug Administration on Tuesday did not approve Neffy, an epinephrine nasal spray from drugmaker ARS Pharmaceuticals, keeping the first needle-free option for Americans to treat severe allergic reactions off the market pending more testing data. ARS had hoped the FDA would approve Neffy for use in adults and children who weigh more … Read more
CONFERENCE REPORTER Results from a recent study showed that flexible-dosing esketamine nasal spray demonstrated sustained improvements in depressive symptoms in adults with treatment-resistant depression (TRD) for up to 6.5 years. Study investigators shared these results in a poster presentation at Psych Congress 2023. The poster presentation, titled Long-Term Efficacy of Esketamine Nasal Spray Dosed According … Read more